# XARACOLL
> **NDA209511** · New Drug Application · Sponsor: INNOCOLL PHARMS · Approved 2020-08-28
## Drug
- **FDA Application Number:** NDA209511
- **Application type:** New Drug Application
- **Brand name:** XARACOLL
- **Generic name:** Bupivacaine Hydrochloride
- **Active ingredients:** BUPIVACAINE HYDROCHLORIDE
- **Dosage form:** IMPLANT
- **Route:** IMPLANTATION
- **Marketing status:** Discontinued
- **Sponsor:** INNOCOLL PHARMS
- **First approval:** 2020-08-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209511)
---
*MORVS · CC0 1.0*